Cell and tissue engineering for liver disease
Name
Cell and tissue engineering.pdf
Size
2.24 MB
Format
Adobe PDF
Checksum (MD5)
e6e9322f7dc2cbe65b31cc101be2231d
Author(s)
Zaret, K. S.
Fox, I. J.
Bhatia, Sangeeta N
Underhill, Gregory
Date Issued
July 2016
Journal
Science Translational Medicine
Publisher
American Association for the Advancement of Science (AAAS)
Citation
Bhatia, S. N., G. H. Underhill, K. S. Zaret, and I. J. Fox. “Cell and Tissue Engineering for Liver Disease.” Science Translational Medicine 6, no. 245 (July 16, 2014): 245sr2–245sr2.
Version
Author's final manuscript
Abstract
Despite the tremendous hurdles presented by the complexity of the liver’s structure and function, advances in liver physiology, stem cell biology and reprogramming, and the engineering of tissues and devices are accelerating the development of cell-based therapies for treating liver disease and liver failure. This State of the Art Review discusses both the near- and long-term prospects for such cell-based therapies and the unique challenges for clinical translation.
MIT Department
Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Harvard University--MIT Division of Health Sciences and Technology
Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1126/scitranslmed.3005975
